Immuno-oncology

Category

University of Louisville’s Brown Cancer Center Embraces Immuno-Oncology Developed at NCI: Some Patients See Dramatic Results

A 46 year-old man residing in the Louisville, Kentucky area was given about six months to live, according to a physician’s grim forecast. With stage four lung cancer that August, Tony Burton’s options for life narrowed but he sought out a second opinion with Dr. Jason...

MERECA Study Reveals Survival Benefits for Metastatic Synchronous mRCC with Combo of Ilixadencel plus Sutent

The combination of ilixadencel plus sunitinib (Sutent) has evidenced favorable survival compared with sunitinib alone in patient with newly diagnosed metastatic synchronous renal cell carcinoma (mRCC), clinical sponsor Immunicum AB recently announced and will present...

Thomas Gajewski, MD, PhD, University of Chicago Material Contribution to Immuno-Oncology

Thomas Gajewski, MD, PhD, AbbVie Foundation Professor of Cancer Immunotherapy in the Ben May Department for Cancer Research and Professor of Pathology and Medicine at the University of Chicago, was named by the European Society for Medical Oncology (ESMO) as the...

Pin It on Pinterest